Research Article
Comparison of Two Waves of COVID-19 in Critically Ill Patients: A Retrospective Observational Study
Table 4
Comparison of risk factors for AKI.
| Covariate | Overall | First wave | Second wave | Adj. HR (95% CI) | -value | Adj. HR (95% CI) | -value | Adj. HR (95% CI) | -value |
| Patient characteristics | Age | <40 years | Reference | | Reference | | Reference | | 40–70 years | 2.2 (1.1–4.4) | 0.02 | 2.4 (0.95–6.1) | 0.07 | 1.3 (0.47–3.7) | 0.61 | >70 years | 3.1 (1.54–6.05) | <0.01 | 2.9 (1.14–7.54) | 0.03 | 2.2 (0.78–6.17) | 0.14 | Female sex | 0.9 (0.71–1.16) | 0.43 | 0.8 (0.59–1.12) | 0.21 | 1 (0.7–1.52) | 0.89 | Past medical history | Chronic kidney disease | 2.3 (1.67–3.2) | <0.01 | 2 (1.28–3.2) | <0.01 | 2.6 (1.62–4.24) | <0.01 | Diabetes | 1.2 (0.95–1.55) | 0.13 | 1.4 (1.02–1.95) | 0.04 | 1 (0.65–1.41) | 0.83 | Hypertension | 1.2 (0.87–1.54) | 0.33 | 1.1 (0.73–1.61) | 0.68 | 1.2 (0.77–1.85) | 0.44 | Cardiovascular disease | 1.1 (0.85–1.44) | 0.44 | 1.1 (0.78–1.59) | 0.55 | 1.3 (0.83–1.88) | 0.29 | Treatment | Remdesivir | 0.7 (0.48–0.88) | 0.01 | 0.5 (0.3–0.74) | <0.01 | 0.9 (0.52–1.43) | 0.57 | Dexamethasone | 0.9 (0.68–1.25) | 0.61 | 0.5 (0.18–1.43) | 0.2 | 1.3 (0.63–2.72) | 0.48 |
|
|